All Bill & Melinda Gates Foundation articles
-
NewsWomen’s health company Freya Biosciences announces key $10.4m strategic investment
Freya Biosciences, a transatlantic biotech company specializing in women’s health, has announced a major strategic investment which will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis.
-
NewsMultidrug-resistant bacterium posing a global public health threat is detected in Northeast Brazil
A strain of Klebsiella pneumoniae that is resistant to all available antibitoics has been detected in Brazil after previously being detected in the United States.
-
NewsGut bacteria of malnourished children benefit from key elements in therapeutic food
Researchers investigating a new therapeutic food aimed at repairing malnourished children’s underdeveloped gut microbiomes has identified key, naturally occurring biochemical components and the important bacterial strains that process these components.
-
News$7.3M grant to expand wheat pathogen surveillance
One of the world’s largest crop pathogen surveillance systems is set to expand its capacity to protect wheat productivity in food vulnerable areas of East Africa and South Asia.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).